{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:09:49Z","timestamp":1787508589896,"version":"build-2736575974"},"reference-count":35,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1185\/030079906x154169","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T11:02:48Z","timestamp":1165057368000},"page":"2575-2590","source":"Crossref","is-referenced-by-count":62,"title":["Effect of tesaglitazar, a dual PPAR\u03b1\/\u03b3 agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12\u2010week dose-ranging trial"],"prefix":"10.1185","volume":"22","author":[{"given":"Barry J.","family":"Goldstein","sequence":"first","affiliation":[{"name":"Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[{"name":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Anzalone","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Tou","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Peter \u00d6hman","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6972.83"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.960"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.9.1551"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.16.1873"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-6-200109180-00014"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/35013000"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2007.S43"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.19.2088"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.32.s3.3.x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1324"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.08.005"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1146"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1846-8"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021864"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000172689.53992.25"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500161-JLR200"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000066131.01313.EB"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.16.1886"},{"key":"CIT0021","unstructured":"Data on file; file ID: CV.000-103-444.1.0; AstraZeneca 2006"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12663-3"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.02.011"},{"key":"CIT0024","unstructured":"Dahl B, Hackett AM, Ljung B, et al. Plasma and total red blood cell volumes in dogs treated orally with tesaglitazar for 14 days. 3rd International Symposium on PPAR Efficacy and Safety, 19\u201323 March 2005. Monte Carlo, Monaco. P34 [abstract 44]"},{"key":"CIT0025","first-page":"42","volume":"102","author":"Festa A","year":"2000","journal-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation"},{"key":"CIT0026","first-page":"226","volume":"2","author":"Standiford TJ","year":"2005","journal-title":"Peroxisome proliferator-activated receptor-\u03b3 as a regulator of lung inflammation and repair. Proc Am Thorac Soc"},{"key":"CIT0027","first-page":"91","volume":"6","author":"Delayre-Orthez C","year":"2005","journal-title":"PPAR\u03b1 down-regulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.6.1364"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"CIT0030","first-page":"434","volume":"64","author":"Kazumi T","year":"2003","journal-title":"Yoshino G. Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and\/or hyper-uricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study. Curr Ther Res"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.12.1993"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.137"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8567"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.3.517"},{"key":"CIT0035","first-page":"742","volume":"45","author":"Haffner SM","year":"1996","journal-title":"The Insulin Resistance Atherosclerosis Study. Diabetes"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X154169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T10:21:51Z","timestamp":1597141311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X154169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["10.1185\/030079906X154169"],"URL":"https:\/\/doi.org\/10.1185\/030079906x154169","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,22]]}}}